Cathie Wood Crispr Therapeutics Ag Call Options Transaction History
Ark Investment Management LLC
- $14 Billion
- Q1 2024
Call Options
1 transactions
Others Institutions Holding CRSP
# of Institutions
549Shares Held
56.3MCall Options Held
2.91MPut Options Held
2.47M-
Capital International Investors Los Angeles, CA7.84MShares$421 Million0.11% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.27MShares$176 Million0.16% of portfolio
-
Nikko Asset Management Americas, Inc.3.27MShares$176 Million2.23% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.7MShares$145 Million0.11% of portfolio
-
Black Rock Inc. New York, NY2.55MShares$137 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.19B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....